Coordinating health and industrial policy in South Africa : a case study of the vaccine public-private partnership

Show simple item record Walwyn, David Richard Nkolele, Adolph T. 2019-07-10T07:01:57Z 2019-07-10T07:01:57Z 2018
dc.description It is acknowledged that this article draws substantially on a previous publication (Walwyn DR, Nkolele AT. An evaluation of South Africa’s public–private partnership for the localisation of vaccine research, manufacture and distribution. Health Research Policy and Systems. 2018;16(1):30). However, the content has been adapted for a South African reader and expanded to include the policy analysis. en_ZA
dc.description.abstract Established in 2003 as a Public-Private Partnership (PPP) covering vaccine research and development, manufacturing and supply, the Biovac Institute has grown from an initial base of 24 staff and a revenue of R188 million to an organisation of 250 people and an annual revenue of R1.8 billion (as of January 2018). The institute earns a premium on the procurement cost of a broad range of vaccines required by the National Department of Health (NDoH), the net value of which reached R1.14 billion over the period 2010–2014 and was used to finance the institute’s operations, including vaccine distribution and quality control. In this study, we have evaluated the value-for-money of the partnership within a context of tension between health and industrial policy. According to the respondents in the qualitative survey, its principal benefit has been the uninterrupted supply of vaccine and the ability to respond quickly to vaccine shortages. The main disadvantages appear to have been the slow establishment of vaccine manufacturing, and initially a limited ability to negotiate highly competitive vaccine prices. Overall, it is concluded that the institute has delivered value-for-money and met the objectives of both industrial and health policy. However, the experience appears not to have convinced the NDoH of the value of such initiatives. en_ZA
dc.description.department Graduate School of Technology Management (GSTM) en_ZA
dc.description.librarian am2019 en_ZA
dc.description.uri en_ZA
dc.identifier.citation Walwyn, D.R. & Nkolele, A.T. 2018, 'Coordinating health and industrial policy in South Africa; a case study of the vaccine public-private partnership', South African Family Practice, vol. 60, no. 4, pp. 42-51. en_ZA
dc.identifier.issn 2078-6190 (print)
dc.identifier.issn 2078-6204 (online)
dc.language.iso en en_ZA
dc.publisher Medpharm Publications, NISC (Pty) Ltd and Cogent, Taylor and Francis Group en_ZA
dc.rights © 2018 The Author(s). Open Access article distributed under the terms of the Creative Commons License [CC BY-NC-ND 4.0]. en_ZA
dc.subject Vaccines en_ZA
dc.subject Cost-benefit analysis en_ZA
dc.subject Local manufacture en_ZA
dc.subject Health security en_ZA
dc.subject Public private partnership (PPP) en_ZA
dc.title Coordinating health and industrial policy in South Africa : a case study of the vaccine public-private partnership en_ZA
dc.type Article en_ZA

Files in this item

This item appears in the following Collection(s)

Show simple item record